Epidemiological and Histopathological Profile of Prostate Cancer in Conakry:: Science Publishing Group

Epidemiological and Histopathological Profile of Prostate Cancer in Conakry

Diallo Thierno Mamadou Oury, Bah Mamadou Bissiriou, Cissé Demba, Agossou Ahouéfa Diodirine, Bah Mamadou Diawo, Diallo Alimou, Diallo Thierno Oumar, Keita Youssouf, Kolié Aimé, Diallo Abdoulaye Bobo, Bah Oumar Raphiou

Corresponding Author: Diallo Thierno Mamadou Oury

Urology-Andrology Department, Ignace Deen National Hospital in Conakry, Conakry, Guinea

Cancer Research Journal, Volume 11, Issue 4, December 2023

Pages: 122-126

Received: Sep. 21, 2023

Accepted: Oct. 30, 2023

Published: Nov. 11, 2023

DOI: 10.11648/j.crj.20231104.11

Downloads:

Views:

Download PDF: Download PDF

Export Citation: Export citation to RIS Export citation to BibTeX

Abstract

Introduction: Prostate cancer is the most common male cancer. The aim of this work was to analyze the evolution of the epidemiological and histopathological profile of prostate cancer in the urology department at the Ignace Deen National Hospital in Conakry. Materials and methods: This was a descriptive retrospective study in 10 years, from January 1, 2011 to December 31, 2020. The data was collected from records available in the archives of the Ignace National Hospital Deen of Conakry. Results: 963 cases of prostate cancer were collected, representing 75% of urogenital cancers. We have observed a constant annual growth of cases, with an annual average of 96 cases. The mean age of the patients was 67 ± 13.56 years, with extremes of [47 - 102 years]. Farmers were the most affected with 36.3% of cases; 9.9% of patients (n=92) were smokers. Patients consulted more often with a delay of more than 12 months. Prostatic adenocarcinoma was the most found histological type with 99.8% of cases. More than half of the patients (62%) had a Gleason score of 3+3 (ISUP 1). Conclusion: Prostate cancer remains frequent representing the first urological cancer in Conakry. Prostatic adenocarcinoma is the main histological type. This study encountered difficulties related to the lack of a reliable data collection system.

Keywords

Prostate Cancer, Conakry, Frenquency, Farmers, Adenocarcinoma

To cite this article

Diallo Thierno Mamadou Oury, Bah Mamadou Bissiriou, Cissé Demba, Agossou Ahouéfa Diodirine, Bah Mamadou Diawo, et al. (2023). Epidemiological and Histopathological Profile of Prostate Cancer in Conakry. Cancer Research Journal, 11(4), 122-126. https://doi.org/10.11648/j.crj.20231104.11

Copyright © 2023 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

References

1.	International Agency for Research on Cancer. GLOBOCAN 2020: estimated cancer incidence, mortality and prevalence worldwide in 2020 [Internet]. https://gco.iarc.fr/today/data/factsheets/cancers/27-Prostate-fact-sheet.pdf
2.	Grosclaude P., Davin J. L., Neuzillet Y., Coulange C. Evolution of the epidémiology of prostate cancer over 20 years. Progrès en Urologie, 2006, 16: 653-660.
3.	Bergengren O, Pekala KR, Matsoukas K, Fainberg J, Mungovan SF, Bratt O, and al. 2022 Update on Prostate Cancer Epidemiology and Risk Factors - A Systematic Review. Eur Urol, 2023; S0302-2838 (23) 02786-0. https://doi.org/10.1016/j.eururo.2023.04.021
4.	Gueye SM, Jalloh M, Labou I, Niang L, Kane R, Ndoye M. Clinical profile of prostate cancer in Senegal. Afr J Urol 2004; 10: 203—7.
5.	Ouattara A, Hodonou R, Avakoudjo J, Cisse D, Zango B, Gandaho I, and al. Epidemiology of urological cancers at the Hubert Koutoukou Maga Cotonou National University Hospital Center. Benign. Analysis of a hospital series of 158 cases. Prog Urol 2012. 22: 261–5. https://doi.org/10.1016/j.purol.2011.12.003
6.	Diallo AB, Bah I, Barry AM, Dombeu NY, Barry M, Diallo MB. Epidemiological characteristics of prostate cancer in Guinea. African Journal of Urology 2008, 14 (3) : 161-167.
7.	Sritharan J, MacLeod JS, McLeod CB, Peter A, Demers PA. Risk of prostate cancer by occupation in the Occupational Disease Surveillance System of Ontario, Canada. Revue PSPMC 2019, 39 (5): 195 -205. https://doi.org/10.24095/hpcdp.39.5.02f
8.	Sauve JF, Lavoue J, Parent ME. Occupation, industry and the risk of prostate cancer: a case-control in Montréal, Canada. Environmental Health. 2016; 15 (1): 100. https://doi.org/10.1186/s12940-016-0185-1
9.	Zeegers MP, Friesema IH, Goldbohm R, Van Den Brandt P. A prospective study of occupation and prostate cancer risk. Journal of Occupational and Environmental Medicine. 2004, 46(3): 271-279. https://doi.org/10.1097/01.jom.0000116961.48464.6b
10.	Ragin C, Davis-Reyes B, Tadesse H, Daniels D, Bunker CH, Jackson M, and al. Farming, reported pesticide use, and prostate cancer. American Journal of Men’s Health. 2013; 7(2): 102-109. https://doi.org/10.1177/1557988312458792
11.	Parent ME, Desy M, Siemiatycki J. Does exposure to agriculture chemicals increase the risk of prostate cancer among farmers? McGill Journal of Medicine. 2009; 12(1): 70-77.
12.	Dosemeci M, Hayes RB, Vetter R, Hoover RN, Tucker M, Engin K et al. Occupational physical activity, socioeconomic status, and risks of 15 cancer sites in Turkey. Cancer Causes Control. 1993, 4: 313-321. https://doi.org/10.1007/bf00051333
13.	Liu Y, Hu F, Li D, Wang F, Zhu L, Chen W, et al. Does physical activity reduce the risk of prostate cancer? A systematic review and metaanalysis. European Urology. 2011, 60: 1029-1044. https://doi.org/10.1016/j.eururo.2011.07.007
14.	Van der Gulden JW, Kolk JJ, Verbeek AL. Work environment and prostate cancer risk. Prostate. 1995; 27(5): 250- 257. https://doi.org/10.1002/pros.2990270504
15.	Le Masters GK, Genaidy AM, Succop P, Deddens J, Sobeih T, Barriera-Viruet H, and al. Cancer risk among firefighters: a review and meta-analysis of 32 studies. Journal of Occupational and Environmental Medicine. 2006; 48(11): 1189-1202. https://doi.org/10.1097/01.jom.0000246229.68697.90
16.	International Center for Research on Cancer Lyon, 2018. Cancers attributable to lifestyle and the environment in metropolitan France. Online at: https://gco.iarc.fr/includes/PAF/PAF_FR_report.pdf
17.	Campedel L, Kossaï M, Blanc-Durand P, Rouprêt M, Seisen T, Compérat E, et al. Neuroendocrine prostate cancer: Natural history, molecular features, therapeutic management and future directions. Bull Cancer. 2017, 104 (9): 789-799. https://doi.org/10.1016/j.bulcan.2017.05.007
18.	Dubois F, Croué A, Ouacel F, Chautard D, Saint-André J-P, Azzouzi AR. Prostate sarcoma. EMC (Elsevier Masson SAS, Paris), Urologie, 18-560-E-10, 2008. https://doi.org/10.1016/S1762-0953(19)73312-3
19.	Amégbor K, Seddoh TY, Tengue K, Songne-Gnamkoulamba B, Napo-Koura G, James K. Epidemiology and histopronostic of prostatic cancer in Togo: About 202 cases diagnosed at the laboratory of pathology of the Tokoin teaching hospital of Lome. Progrès en Urologie. 2009 19 (2): 112–115. https://doi.org/10.1016/j.purol.2008.10.008